Literature DB >> 215349

An enzymic and centrifugal method for estimating high-density lipoprotein cholesterol.

J K Allen, W J Hensley, A V Nicholls, J B Whitfield.   

Abstract

Enzymic measurement of high-density lipoprotein cholesterol with a centrifugal analyzer is described. We used polyethylene glycol (Mr 6000), final concentration 100 g/L, to precipitate low-density and very-low-density lipoproteins, thereby eliminating the difficulties of the commonly used heparin/Mn2+ precipitation method and facilitating the use of ethylenediaminetetraacetate-stabilized plasma. As measured by rocket immunoelectrophoresis, this final concentration of polyethylene glycol completely precipitates beta-lipoproteins, leaving the alpha-lipoproteins in solution. Between-run reproducibility (CV) was 3.6%, within-run reproducibility (CV) 0.8%. Reagent costs currently are $US 0.13 per test and large numbers of samples can be handled conveniently. Normal ranges were compiled for 539 men and 444 women. The high-density lipoprotein cholesterol for men was 1.20 +/- 0.31 (SD) mmol/L and for women 1.52 +/- 0.38 (SD) mmol/L.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 215349

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  8 in total

1.  The nitroxide radical TEMPOL prevents obesity, hyperlipidaemia, elevation of inflammatory cytokines, and modulates atherosclerotic plaque composition in apoE-/- mice.

Authors:  Christine H J Kim; James B Mitchell; Christina A Bursill; Anastasia L Sowers; Angela Thetford; John A Cook; David M van Reyk; Michael J Davies
Journal:  Atherosclerosis       Date:  2015-03-16       Impact factor: 5.162

2.  Low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression in human mononuclear leukocytes is regulated coordinately and parallels gene expression in human liver.

Authors:  E E Powell; P A Kroon
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

3.  The apolipoprotein A-I mimetic peptide, ETC-642, reduces chronic vascular inflammation in the rabbit.

Authors:  Belinda A Di Bartolo; Laura Z Vanags; Joanne Tm Tan; Shisan Bao; Kerry-Anne Rye; Philip J Barter; Christina A Bursill
Journal:  Lipids Health Dis       Date:  2011-11-30       Impact factor: 3.876

4.  Mouse, but not human, ApoB-100 lipoprotein cholesterol is a potent innate inhibitor of Streptococcus pneumoniae pneumolysin.

Authors:  Kristin R Wade; Eileen M Hotze; David E Briles; Rodney K Tweten
Journal:  PLoS Pathog       Date:  2014-09-04       Impact factor: 6.823

5.  A novel class of copper(II)- and zinc(II)-bound non-steroidal anti-inflammatory drugs that inhibits acute inflammation in vivo.

Authors:  Rajesh Puranik; Shisan Bao; Antonio M Bonin; Ravinder Kaur; Jane E Weder; Llewellyn Casbolt; Trevor W Hambley; Peter A Lay; Philip J Barter; Kerry-Anne Rye
Journal:  Cell Biosci       Date:  2016-02-06       Impact factor: 7.133

6.  The Cholesteryl Ester Transfer Protein Inhibitor, des-Fluoro-Anacetrapib, Prevents Vein Bypass-induced Neointimal Hyperplasia in New Zealand White Rabbits.

Authors:  Ben J Wu; Yue Li; Kwok-Leung Ong; Yidan Sun; Douglas Johns; Philip J Barter; Kerry-Anne Rye
Journal:  Sci Rep       Date:  2019-11-07       Impact factor: 4.996

7.  Plasma lipids and prolactin in patients with breast cancer.

Authors:  I A Bani; C M Williams; P S Boulter; J W Dickerson
Journal:  Br J Cancer       Date:  1986-09       Impact factor: 7.640

8.  Serum lipid profile in patients with oral cancer and oral precancerous conditions.

Authors:  Rajul Mehta; Shubha Gurudath; Sujatha Dayansoor; Anuradha Pai; K S Ganapathy
Journal:  Dent Res J (Isfahan)       Date:  2014-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.